UK markets closed

Bionano Genomics, Inc. (BNGO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.16-0.03 (-0.57%)
As of 2:14PM EDT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 51.72B
Enterprise value 31.38B
Trailing P/E N/A
Forward P/E 1-29.31
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)162.92
Price/book (mrq)4.73
Enterprise value/revenue 3130.89
Enterprise value/EBITDA 7-37.45

Trading information

Stock price history

Beta (5Y monthly) 1.99
52-week change 3673.75%
S&P500 52-week change 335.56%
52-week high 315.69
52-week low 30.47
50-day moving average 36.81
200-day moving average 37.82

Share statistics

Avg vol (3-month) 319.5M
Avg vol (10-day) 38.9M
Shares outstanding 5278.85M
Implied shares outstanding 6N/A
Float 275.8M
% held by insiders 10.34%
% held by institutions 116.87%
Shares short (14 Jul 2021) 444.92M
Short ratio (14 Jul 2021) 42.89
Short % of float (14 Jul 2021) 416.11%
Short % of shares outstanding (14 Jul 2021) 416.11%
Shares short (prior month 14 Jun 2021) 438.26M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-365.00%

Management effectiveness

Return on assets (ttm)-11.90%
Return on equity (ttm)-22.62%

Income statement

Revenue (ttm)10.53M
Revenue per share (ttm)0.06
Quarterly revenue growth (yoy)178.90%
Gross profit (ttm)2.77M
EBITDA -36.82M
Net income avi to common (ttm)-40.54M
Diluted EPS (ttm)-0.25
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)362.06M
Total cash per share (mrq)1.3
Total debt (mrq)14.87M
Total debt/equity (mrq)4.10
Current ratio (mrq)51.65
Book value per share (mrq)1.30

Cash flow statement

Operating cash flow (ttm)-44.19M
Levered free cash flow (ttm)-20.67M